Joshua Meeks, MD
Urology · Chicago, ILNPI 1821248014
Payments from drug & device makers
Across 411 payments — averaging $4834.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$988K
- Janssen Research & Development, LLC$645K
- Pfizer$76K
- Olympus Corporation Of The Americas$54K
- Photocure Inc$40K
- Incyte Corporation$25K
- plus $159K from 20 others
Across 1 payment — averaging $451.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$451
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 26 | $987,721 |
| Janssen Research & Development, LLC | 137 | $645,293 |
| Pfizer | 13 | $75,853 |
| Olympus Corporation Of The Americas | 103 | $54,245 |
| Photocure Inc | 26 | $40,169 |
| Incyte Corporation | 1 | $25,242 |
| Urogen Pharma, Inc. | 7 | $25,183 |
| Ferring Pharmaceuticals Inc. | 15 | $24,895 |
| Astrazeneca UK Limited | 24 | $22,153 |
| Seagen Inc. | 4 | $21,044 |
| AstraZeneca | 11 | $19,167 |
| Janssen Global Services, LLC | 19 | $15,615 |
| Ferring Pharmaceuticals AS | 2 | $11,284 |
| Foundation Medicine, Inc. | 4 | $4,387 |
| E.r. Squibb & Sons, L.L.C. | 2 | $3,814 |
| Astellas Pharma Global Development | 4 | $3,599 |
| Immunitybio, Inc. | 1 | $2,400 |
| Astellas Pharma US Inc | 3 | $2,384 |
| Olympus Corporation | 2 | $900 |
| Janssen Scientific Affairs, LLC | 1 | $758 |
| Gyrus ACMI, Inc. | 1 | $730 |
| Medical Device Business Services, Inc. | 1 | $108 |
| Genentech, Inc. | 1 | $57 |
| Antares Pharma, Inc. | 1 | $44 |
| Olympus America Inc. | 1 | $23 |
| Hollister Incorporated | 1 | $14 |
How this compares
$1,987,080 in reported general payments places this provider in the 95th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Chicago
- Ashley RossChicago$2.3M
- Courtney HollowellChicago$1.9M
- Gary SteinbergChicago$1.4M
- Brian HelfandChicago$1.2M
- Simone CrivellaroChicago$1.1M
- Michael AbernChicago$1M
- Roohollah SharifiChicago$828K
- Amy KrambeckChicago$700K
- Srinivas VourgantiChicago$297K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.